Investment Director of Science Park: The amount of investment in the global start-up market has risen slightly this year, and pharmaceutical projects are easily favored

Financial News

Written by: Kuang Yueting

2021-03-03 08:00

Last update date: 2021-03-03 08:00

With the launch of the vaccination program in Hong Kong, the economy is expected to pick up and the start-up market atmosphere can improve.

Huang Xianmin, the investment director of the Science Park, said that the amount of investment in the global and Asian start-up markets this year was slightly higher than last year. Investors tend to look for high-quality investment projects. Investing in a larger "silver code" in one go has reduced the number of investment projects.

Among them, many investors favor projects such as online shopping, biotechnology, rapid testing, drugs, and medical systems.

"Investors are not allowed to stay under the epidemic. We hold meetings through video conferences. Don't face to face. Time is easy to fix. Zhong Qing will go to the left!"

Asked if he would be worried about the brain drain caused by immigration, Huang Xianmin said that last year the Science Park provided more than 1,100 jobs and attracted 60,000 job seekers from 100 different countries or regions. Although only more than 100 people were hired in the end, But this reflects that many talents are optimistic about the prospects of Hong Kong. In the future, the Science and Technology Park will continue to do job matching and strive to increase the matching success rate.

The Science Park Venture Capital Fund has recently received an injection of 350 million yuan from the government, and the total fund will be expanded to 600 million yuan.

Huang Xianmin believes that after the capital increase, the fund will have greater flexibility. The scope of coverage will be expanded from the A round to the B round or later financing. It can invest in start-up companies of different maturity levels. Recently, the Science and Technology Park invested in the medical robot company Precision Robotics ( Prime Medical), the medical robot arm developed by the company can be used in a variety of operations. In the future, the aging problem of Hong Kong's population will become more and more serious. I believe that such products have great commercialization potential.

In addition to providing facilities such as laboratories and scenes for the company, the Science and Technology Park will also introduce partners and look for investors to inject capital.

The surgical robotic arm developed by Prime Medical can be used in single-port and non-port surgery, and can be used to perform operations on diseases such as the lungs, digestive system, urinary, and obstetrics.

In the case of non-porous surgery, the patient only needs anesthesia, and after the operation, they can even be discharged on the same day or every other day.

Yang Guangzhong, the director and founder of Prime Medical, pointed out that surgical robots have become more and more obvious in clinical applications in the past few years, which can help early detection of disease signs and can be used for minimally invasive surgery. The company's surgical robot arms are better than the market. Similar products are smaller, more dexterous and smarter, and the cost will be more affordable.

Primus Medical’s surgical robotic arm is currently in the stage of animal experiments and clinical trials. It is expected to complete human clinical trials in the first half of this year and formally begin the next round of financing in the second half of this year.

He continued that the company is currently doing research and development work in Hong Kong and London, as well as small batch manufacturing processes, and will consider mass production in the Science Park and the Greater Bay Area in the future.

"I am very optimistic about the Greater Bay Area. Hong Kong can provide professional services and talents with a broad international perspective. The Hong Kong government also supports the development of innovation and technology!"

The medical device market has a huge prospect. According to a white paper published by the accounting firm Deloitte on March 1, the size of the Chinese medical device market in 2020 is expected to be 800 billion yuan (RMB, the same below), an increase of more than 308 billion yuan in 2015. Doubled.

Since 2015, the industry’s average annual growth rate has remained at around 20%, and the growth rate in recent years has consistently surpassed that of GDP.

Cyberport: The "Photograph and Live" project will start accepting applications today and receive up to $150,000 in funding

Budget | Cyberport injects 200 million yuan into investment venture funds to strengthen start-up financing support

Science Park hosts an online career expo next month, over 240 technology companies provide about 1,500 jobs

Hong Kong Science and Technology Park Startups